NCT04533672View on ClinicalTrials.gov

Multiparametric Magnetic Resonance Imaging (MRI) to Improve Bladder Cancer Staging and Treatment Decision-making

NARecruitingINTERVENTIONAL

Enrollment

182

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

February 1, 2026

Study Completion Date

October 1, 2026

Conditions

Bladder Cancer

Interventions

DIAGNOSTIC_TEST

MRI Sequences

New multiparametric MRI techniques

Trial Locations (1)

8091

RECRUITING

University Hospital Zurich, Zurich

All Listed Sponsors

collaborator

Swiss National Science Foundation

OTHER

lead

University of Zurich

OTHER

NCT04533672 - Multiparametric Magnetic Resonance Imaging (MRI) to Improve Bladder Cancer Staging and Treatment Decision-making | Biotech Hunter | Biotech Hunter